PICO 7 treatment (pegylated interferon and ribavirin vs DAAs): decision making table
World Health Organization. (2014). PICO 7 treatment (pegylated interferon and ribavirin vs DAAs): decision making table. World Health Organization. http://www.who.int/iris/handle/10665/133846
DescriptionAnnex to Guidelines for the screening, care and treatment of persons with hepatitis C infection ISBN 9789241548755
Gov't Doc #WHO/HIV/2014.40
MetadataShow full item record
Showing items related by title and MeSH subject.
PICO 6: treatment: pegylated interferon plus ribavirin versus standard interferon plus ribavirin for chronic hepatitis C infection: a meta-analytical systematic review World Health Organization (WHO/HIV/2014.32, 2014)
Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major Saffar, M.J.; Saffar, H.; Khalilian, A.R.; Naqshvar, F. (2009)Treatment of chronic hepatitis C virus [HCV] infection in transfusion-dependent betathalassaemia major patients is complicated by existing hepatic siderosis and the fear of ribavirinassociated haemolysis. We evaluated the efficacy and side-effects of combination interferon-alpha [INF] and ribavirin therapy for HCV-infected thalassaemia patients. A total of 17 patients were enrolled [10 nonresponders to INF monotherapy, 7 naive to treatment, mean age 23.1 years] and they received 12 months of combination therapy. The sustained virological response ...
PICO 7: treatment: direct acting antiviral therapy versus pegylated interferon and ribavirin treatment for chronic hepatitis C infection: a meta-analytical systematic review World Health Organization (WHO/HIV/2014.33, 2014)